Bioqual Debt to Equity Ratio 2010-2024 | BIOQ
Current and historical debt to equity ratio values for Bioqual (BIOQ) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Bioqual debt/equity for the three months ending November 30, 2024 was 0.00.
| Bioqual Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-11-30 |
$0.02B |
$0.04B |
0.65 |
| 2024-08-31 |
$0.02B |
$0.04B |
0.46 |
| 2024-05-31 |
$0.02B |
$0.04B |
0.50 |
| 2024-02-29 |
$0.02B |
$0.04B |
0.52 |
| 2023-11-30 |
$0.02B |
$0.04B |
0.54 |
| 2023-08-31 |
$0.02B |
$0.04B |
0.60 |
| 2023-05-31 |
$0.02B |
$0.04B |
0.63 |
| 2023-02-28 |
$0.02B |
$0.04B |
0.61 |
| 2022-11-30 |
$0.03B |
$0.04B |
0.62 |
| 2022-08-31 |
$0.03B |
$0.04B |
0.67 |
| 2022-05-31 |
$0.03B |
$0.04B |
0.68 |
| 2022-02-28 |
$0.03B |
$0.04B |
0.73 |
| 2021-11-30 |
$0.03B |
$0.04B |
0.76 |
| 2021-08-31 |
$0.02B |
$0.04B |
0.54 |
| 2021-05-31 |
$0.02B |
$0.03B |
0.59 |
| 2021-02-28 |
$0.02B |
$0.03B |
0.60 |
| 2020-11-30 |
$0.02B |
$0.03B |
0.69 |
| 2020-08-31 |
$0.02B |
$0.03B |
0.69 |
| 2020-05-31 |
$0.02B |
$0.03B |
0.76 |
| 2020-02-29 |
$0.02B |
$0.03B |
0.77 |
| 2019-11-30 |
$0.02B |
$0.03B |
0.83 |
| 2019-08-31 |
$0.00B |
$0.00B |
0.00 |
| 2019-05-31 |
$0.00B |
$0.03B |
0.15 |
| 2019-02-28 |
$0.00B |
$0.00B |
0.00 |
| 2018-11-30 |
$0.00B |
$0.00B |
0.00 |
| 2018-08-31 |
$0.00B |
|
0.00 |
| 2018-05-31 |
$0.00B |
$0.02B |
0.19 |
| 2018-02-28 |
$0.00B |
|
0.00 |
| 2017-11-30 |
$0.00B |
|
0.00 |
| 2017-08-31 |
$0.00B |
|
0.00 |
| 2017-05-31 |
$0.00B |
|
0.00 |
| 2017-02-28 |
$0.00B |
|
0.00 |
| 2016-11-30 |
$0.00B |
|
0.00 |
| 2016-08-31 |
$0.00B |
|
0.00 |
| 2016-05-31 |
$0.00B |
|
0.00 |
| 2016-02-29 |
$0.00B |
|
0.00 |
| 2015-11-30 |
$0.00B |
|
0.00 |
| 2015-08-31 |
$0.00B |
|
0.00 |
| 2015-05-31 |
$0.00B |
|
0.00 |
| 2015-02-28 |
$0.00B |
|
0.00 |
| 2014-08-31 |
$0.00B |
|
0.00 |
| 2014-05-31 |
$0.00B |
|
0.00 |
| 2013-11-30 |
$0.00B |
|
0.00 |
| 2013-08-31 |
$0.00B |
|
0.00 |
| 2013-05-31 |
$0.00B |
|
0.00 |
| 2012-05-31 |
$0.00B |
|
0.00 |
| 2012-02-29 |
$0.00B |
|
0.00 |
| 2011-11-30 |
$0.00B |
|
0.00 |
| 2011-08-31 |
$0.00B |
|
0.00 |
| 2011-05-31 |
$0.00B |
|
0.00 |
| 2011-02-28 |
$0.00B |
|
0.00 |
| 2010-11-30 |
$0.00B |
|
0.00 |
| 2010-08-31 |
$0.00B |
|
0.00 |
| 2010-05-31 |
$0.00B |
|
0.00 |
| 2010-02-28 |
$0.00B |
|
0.00 |
| 2009-11-30 |
$0.00B |
|
0.00 |
| 2009-08-31 |
$0.00B |
$0.00B |
0.00 |
| 2009-05-31 |
$0.00B |
$0.00B |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.055B |
$0.059B |
|
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
|
